New drugs that overcome antibiotic resistance may be headed for clinical trials
Gram-negative bacteria have an external membrane that prevents antibiotics from penetrating. Increasing multi-drug resistance in Gram-negative bacteria is becoming a major public health challenge and the EU-funded GNA NOW project is rising to meet it. As part of the EU's new Antimicrobial Resistance Accelerator (AMR) Programme, academic and industry experts plan to discover and test the most promising antibiotic compounds over the next six years and bring a handful of them to clinical trials.
Fields of science
Call for proposal
See other projects for this call
Funding SchemeIMI2-RIA - Research and Innovation action